Maersk launches dedicated reefer rail corridor linking Hyderabad pharma hub with Nhava Sheva Port
- May 15
- 3 min read
A.P. Moller – Maersk has launched its first dedicated weekly reefer rail service connecting Hyderabad’s pharmaceutical manufacturing cluster with Nhava Sheva Port near Mumbai, marking a significant step forward in India’s cold-chain logistics infrastructure for pharmaceutical exports.
Developed in partnership with Container Corporation of India (CONCOR), the new corridor is designed to provide pharmaceutical exporters with a predictable, temperature-controlled, and lower-emission alternative to traditional road transportation. The service is expected to reduce greenhouse gas emissions by up to 3,000 tonnes annually while improving supply chain reliability for temperature-sensitive cargo.
The weekly rail connection operates on a fixed schedule using 40-foot refrigerated containers and has been purpose-built for Hyderabad’s growing pharmaceutical export sector, one of the most important pharma manufacturing hubs in Asia. Pre-trip inspection compliance and pharma-grade container selection are integrated into every shipment in order to meet strict cold-chain quality standards required for sensitive medical products and life sciences cargo.
Building an Integrated End-to-End Cold Chain
A central element of the new Hyderabad–Nhava Sheva corridor is its fully integrated logistics model. Under a single-window arrangement, Maersk assumes responsibility across inland rail transportation, ocean freight services, shipment monitoring, and end-to-end visibility throughout the cargo journey.
The solution has been specifically designed to support export routes to North America’s East Coast ports including Newark, Norfolk, Charleston, and Savannah, as well as Latin America, Europe, and other reefer cargo destinations. In addition to transportation services, pharmaceutical exporters will also receive documentation support, compliance assistance, cold-chain advisory services, and destination trucking solutions where required.
The initiative reflects the growing demand within the pharmaceutical industry for logistics systems capable of maintaining uninterrupted temperature integrity while simultaneously reducing operational variability. Compared to road transportation, rail-based reefer logistics offer more stable transit schedules, lower exposure to traffic disruptions, and reduced risks linked to driver fatigue and regulatory stoppages.
Supporting India’s Expanding Pharmaceutical Export Sector
India continues to strengthen its position as one of the world’s leading pharmaceutical exporters, increasing pressure on logistics providers to develop infrastructure capable of handling high-value and temperature-sensitive products at scale.
According to Thomas Theeuwes, the new rail corridor aligns with Maersk’s broader strategy of expanding integrated logistics infrastructure across India while supporting industries that require highly reliable supply chains.
The project also demonstrates the increasing role of rail freight within India’s logistics modernization strategy. By shifting refrigerated pharmaceutical cargo from road to rail, the service not only improves operational predictability but also contributes toward broader sustainability objectives and supply chain decarbonization efforts.
Lower Emissions and Greater Supply Chain Resilience
Based on current shipment projections, the modal shift from truck transport to rail is expected to eliminate approximately 3,000 tonnes of greenhouse gas emissions annually. The environmental benefits are expected to grow further as export volumes increase and more pharmaceutical manufacturers transition toward rail-based cold-chain logistics.
The initiative also supports Maersk’s wider Net Zero 2040 targets, which focus on reducing emissions across ocean freight, inland transportation, warehousing, and integrated logistics operations. The reefer rail service forms part of the company’s broader expansion of cold-chain and intermodal logistics solutions in India and other high-growth export markets.
A New Benchmark for Pharmaceutical Logistics in India
The Hyderabad–Nhava Sheva reefer rail corridor highlights the ongoing transformation of pharmaceutical logistics toward integrated, technology-driven, and sustainability-focused supply chains. As pharmaceutical exports continue growing globally, demand is increasing for logistics systems capable of combining compliance, visibility, temperature integrity, and environmental performance within a single operational framework.
By integrating rail infrastructure, refrigerated transport technology, and end-to-end logistics management, Maersk and CONCOR are positioning the new corridor as a scalable model for future pharmaceutical cold-chain development across India. The project also reflects a broader shift within the logistics sector, where resilience, emissions reduction, and cargo integrity are becoming as strategically important as transit speed and freight capacity.
Image source: maersk.com
